This benzoxaborole derivative is primarily utilized in the development of pharmaceutical agents due to its unique boronic acid functionality, which potently inhibits enzymes such as leucyl-tRNA synthetase. It has shown potential in the treatment of bacterial and fungal infections by disrupting microbial protein synthesis. Additionally, it is being researched for anti-inflammatory properties, making it a candidate for managing chronic inflammatory diseases. Its ability to form stable complexes with biological molecules (e.g., via diol binding) also makes it valuable in targeted drug delivery systems.